Answers are grounded in this paper and cite their sources.
The anti-influenza drug oseltamivir is an ester prodrug activated by hepatic carboxylesterases. Plasma esterases also convert up to 31.8% of the parent compound to the active metabolite after 4 h ex vivo, with wide interindividual variation. This source of error is removed by adding the esterase inhibitor dichlorvos to blood collection tubes.
No takes yet. Share an insight, caveat, or question.
Lindegårdh et al. (2006) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: